VIAD PHARMA ApS: Financial statements 2019
CVR: 36433892
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,410,155 and a net result of DKK 554,640 compared with DKK 552,786 the year before. That is an increase of 2.8% compared with the year before. Equity in the 2019 report amounted to DKK 668,367. The solvency ratio was 65.2%.
- Gross Profit
- DKK 1,410,155
- Profit/Loss
- DKK 554,640
- Equity
- DKK 668,367
- Total Assets
- DKK 1,025,505
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.4 mio. | 555 t. | 668 t. | - |
| 2018 | - | 1.4 mio. | 553 t. | 714 t. | - |
| 2017 | - | 1.5 mio. | 677 t. | 761 t. | - |
| 2016 | - | 1.4 mio. | 623 t. | 684 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
VIAD PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 1,371,505, and the net result was DKK 552,786.
About VIAD PHARMA ApS
VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity in the 2025 report amounted to DKK 236,399.